EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Cardiovascular–Kidney–Metabolic Syndrome Stages, Echocardiographic Characteristics, and Heart Failure Risk: The Atherosclerosis Risk in Communities Study

Mats C Højbjerg Lassen iD, John W Ostrominski iD, Brian L Claggett iD, Chiadi E Ndumele iD, Tor Biering-Sørensen iD, Kunihiro Matsushita iD, Elizabeth Selvin iD, Josef Coresh iD, Amil Shah iD, Scott D Solomon iD, Muthiah Vaduganathan iD

Circulation · 28.04.2026 · 153 (17) · 1268-1280

DOI: 10.1161/circulationaha.125.077894 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Circulation, erschienen am 28.04.2026. Verfasst von Mats C Højbjerg Lassen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (M.C.H.L., J.W.O., B.L.C., S.D.S., M.V.). Hauptthemen laut MEDLINE: Atherosclerosis, Echocardiography, Heart Failure, Metabolic Syndrome. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Suboptimal cardiovascular–kidney–metabolic (CKM) health is highly prevalent in the United States, especially among older adults, but whether the CKM syndrome staging framework is predictive of incident heart failure (HF) in this population remains uncertain. METHODS: Participants from the ARIC Study (Atherosclerosis Risk in Communities; visit 5, 2011–2013) who underwent echocardiography were categorized according to the American Heart Association CKM syndrome staging framework, which is based on excess or dysfunctional adiposity, metabolic risk factors, kidney disease, subclinical cardiovascular disease (CVD), and clinical CVD. We evaluated the association between CKM stage and prevalence and progression of cardiac remodeling and longitudinal risk of incident HF. RESULTS: Of the 5646 participants who had data available for CKM staging (age range, 66 to 90 years; 3271 women [57.9%]), 24 (0.4%) were stage 0 (optimal CKM health), 104 (1.8%) stage 1, 460 (8.1%) stage 2, 3197 (56.0%) stage 3, 1842 (32.3%) stage 4a, and 19 (0.3%) stage 4b. Higher CKM stage was incrementally associated with adverse left ventricular remodeling, worse left ventricular systolic and diastolic function, and greater progression of adverse remodeling by visit 7 (2018–2019). Among participants without prevalent HF at visit 5 (n=4827), the risk of incident HF during follow-up (656 events; median follow-up time, 9.0 years) increased with higher CKM syndrome stage: stage 0/1, 0 events per 1000 person-years; stage 2, 2.9 events/1000 person-years (referent due to no events in stage 0/1); stage 3, 15.1 events/1000 person-years (adjusted hazard ratio, 3.6 [95% CI, 2.1–6.0]); stage 4, 37.4 events/1000 person-years (adjusted hazard ratio, 8.3 [95% CI, 4.9–14.2]; P trend

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisEchocardiographyHeart FailureMetabolic SyndromeAgedAged, 80 and overFemaleHumansMaleDisease ProgressionIncidencePrevalenceProspective StudiesRisk FactorsUnited StatesVentricular Remodeling

Stichwörter der Autor:innen

cohort studiesechocardiographyheart failureprevention & control

Autor:innen und Institutionen

  • Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (M.C.H.L., J.W.O., B.L.C., S.D.S., M.V.).
  • Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Herlev and Gentofte Hospital (M.C.H.L., T.B.-S.), University of Copenhagen, Denmark.
  • Department of Biomedical Sciences, Faculty of Health and Medical Sciences, Center for Translational Cardiology and Pragmatic Randomized Trials (M.C.H.L., T.B.-S.), University of Copenhagen, Denmark.
  • Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD (C.E.N., K.M., E.S., J.C.).
  • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (K.M., E.S.).
  • University of Texas Southwestern Medical Center, Dallas (A.S.).

ORCID-Profile: Mats C Højbjerg Lassen, John W Ostrominski, Brian L Claggett, Chiadi E Ndumele, Tor Biering-Sørensen, Kunihiro Matsushita, Elizabeth Selvin, Josef Coresh, Amil Shah, Scott D Solomon, Muthiah Vaduganathan

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Lassen, M. C. H., Ostrominski, J. W., Claggett, B. L., Ndumele, C. E., Biering-Sørensen, T., Matsushita, K., Selvin, E., Coresh, J., Shah, A., Solomon, S. D., & Vaduganathan, M. (2026). Cardiovascular–Kidney–Metabolic Syndrome Stages, Echocardiographic Characteristics, and Heart Failure Risk: The Atherosclerosis Risk in Communities Study. Circulation, 153(17), 1268-1280. https://doi.org/10.1161/circulationaha.125.077894

Vancouver

Lassen MCH, Ostrominski JW, Claggett BL, Ndumele CE, Biering-Sørensen T, Matsushita K, et al. Cardiovascular–Kidney–Metabolic Syndrome Stages, Echocardiographic Characteristics, and Heart Failure Risk: The Atherosclerosis Risk in Communities Study. Circulation. 2026;153(17):1268-1280. doi:10.1161/circulationaha.125.077894

BibTeX
@article{Lassen2026,
  author = {Lassen, Mats C Højbjerg and Ostrominski, John W and Claggett, Brian L and Ndumele, Chiadi E and Biering-Sørensen, Tor and Matsushita, Kunihiro and Selvin, Elizabeth and Coresh, Josef and Shah, Amil and Solomon, Scott D and Vaduganathan, Muthiah},
  title = {Cardiovascular–Kidney–Metabolic Syndrome Stages, Echocardiographic Characteristics, and Heart Failure Risk: The Atherosclerosis Risk in Communities Study},
  journal = {Circulation},
  year = {2026},
  volume = {153},
  number = {17},
  pages = {1268--1280},
  doi = {10.1161/circulationaha.125.077894}
}
Kostenlos starten →